| 000 | 01875 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515054318.0 | ||
| 264 | 0 | _c20071206 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1472-9792 | ||
| 024 | 7 |
_a10.1016/j.tube.2006.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHartkoorn, Ruben C | |
| 245 | 0 | 0 |
_aDifferential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. _h[electronic resource] |
| 260 |
_bTuberculosis (Edinburgh, Scotland) _cMay 2007 |
||
| 300 |
_a248-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aColorimetry |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 |
_aEthambutol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aOxazines |
| 650 | 0 | 4 | _aPhagocytosis |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 650 | 0 | 4 | _aXanthenes |
| 700 | 1 | _aChandler, Becky | |
| 700 | 1 | _aOwen, Andrew | |
| 700 | 1 | _aWard, Stephen A | |
| 700 | 1 | _aBertel Squire, S | |
| 700 | 1 | _aBack, David J | |
| 700 | 1 | _aKhoo, Saye H | |
| 773 | 0 |
_tTuberculosis (Edinburgh, Scotland) _gvol. 87 _gno. 3 _gp. 248-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tube.2006.12.001 _zAvailable from publisher's website |
| 999 |
_c16820771 _d16820771 |
||